Arctoris

Arctoris

A biotechnology company with a drug discovery platform intended to be used for research purposes. It was founded in 2016 and has offices in Oxford, England and Singapore.

About

Arctoris is an Oxford-based biotechnology and artificial intelligence company that has developed a platform to be used for the research and development of drugs for diseases such as cancer. The platform is used in industries such as biotechnology, pharmaceuticals, academia, and artificial intelligence drug discovery.

Product

The platform allows for researchers to design their experiment with an online configurator and also gives them access to a team of experts prior the initiation of the experiment. Arctoris then has its own robotics perform the experiments remotely as per the researchers' specifications. Researchers can see the results of the experiment in real-time using the platform.

The platform works with in silico drug discovery and provides a range of assays and techniques. The company offers services for both cell-based assays and target-based assays.During the COVID-19 pandemic, Arctoris offered services such as biochemical profiling, molecular assays, and its cellular assays.

Timeline

People

Name
Role
LinkedIn

Jack Henderson

Employee

Kilian R. Dinkelaker

Co-Founder and CFO

Martin-Immanuel Bittner

Co-Founder and CEO

Sitthichok Chaichulee

Employee

Tom Fleming

Co-Founder and COO

Further reading

Title
Author
Link
Type
Date

Arctoris announces partnership with Molecule to tackle the innovation crisis in drug discovery and development

Web

February 10, 2020

Arctoris Ltd Secures Seed Funding of £3.2 Million to Advance Novel Drug Discovery Platform Powered by Robotics

Web

September 30, 2019

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.